How to Help Your Patients Find Molnupiravir in Stock: A Provider's Guide

You've just written a prescription for molnupiravir. Your patient is high-risk, Paxlovid has too many interactions with their medication regimen, and IV remdesivir isn't logistically feasible. Molnupiravir is the right call. But within hours, your patient calls back: "I went to three pharmacies and none of them have it."

This guide gives you a practical, stepwise workflow for helping your patients actually find molnupiravir in stock — efficiently, before the 5-day treatment window closes.

The Core Problem: Localized Stock Gaps

Molnupiravir is not in active national shortage — but it is stocked inconsistently at the individual pharmacy level. Because it is the third-line COVID-19 treatment with lower prescription volume than Paxlovid, many pharmacies stock limited quantities or skip it entirely. The challenge for your patients is that they don't have time to investigate dozens of locations while sick and possibly contagious.

Step 1: Set Expectations at the Point of Prescribing

The single most effective intervention is proactive counseling. When you write the prescription:

Tell the patient: "This medication may not be at every pharmacy. You may need to call several before you find it in stock."

Emphasize timing: "You need to start this within 5 days of your first symptom. Don't wait — call pharmacies today."

Give a backup plan: "If you can't find it within 24 hours, call us back immediately."

Step 2: Send the Prescription to Multiple Pharmacies Simultaneously

If your EHR or e-prescribing platform allows it, consider sending the prescription to two or three pharmacies in your area simultaneously — one large chain, one independent, and one hospital outpatient pharmacy. Instruct the patient to call each one to confirm stock, then pick up from whichever has it available. Only one will fill it; the others will simply hold the unprocessed Rx.

Note: This approach works best in jurisdictions where e-prescribing to multiple pharmacies is not prohibited. Confirm your local regulations or consult your pharmacy partner.

Step 3: Keep a Preferred Pharmacy List in Your Practice

Develop a short list of 3–5 pharmacies in your practice's service area that reliably stock COVID antivirals including molnupiravir. Update this list quarterly. Share it with your clinical staff so they can relay it to patients immediately when asked. A hospital-system pharmacy with inpatient supply chains and a high-volume independent pharmacy that orders specialty antivirals are your best bets.

Step 4: Use medfinder for Real-Time Inventory Lookup

medfinder is a paid service that calls pharmacies near your patient to find which ones have a specific medication in stock. Rather than having a sick patient or your MA make a dozen calls, providers can direct patients to medfinder.com/providers for a structured search. The patient submits their medication, dosage, and zip code. medfinder calls local pharmacies and texts results back within a short window.

Step 5: Consider Hospital Pharmacy Networks

Hospital system outpatient pharmacies and specialty pharmacies often have more reliable COVID antiviral stock than retail chains. If your hospital system has an outpatient pharmacy, it may be able to dispense molnupiravir same-day. This is especially relevant for providers at academic medical centers, federally qualified health centers, or large health systems.

Your Clinical Backup Plan: The 3-Step Decision Tree

If a patient still cannot find molnupiravir within 24 hours of the prescription, follow this decision tree:

Reassess Paxlovid candidacy. Use the Liverpool Drug Interaction tool or the Paxlovid prescribing information to identify all interacting drugs. Consider whether any can be held safely for 5 days while the patient completes antiviral therapy.

Refer for outpatient remdesivir. A 3-day infusion course is a strong second-line option. Arrange a referral to an infusion center or hospital outpatient department if feasible.

Escalate to close monitoring. If no antiviral is accessible, set up a clear monitoring plan — daily check-ins, objective symptom tracking, pulse oximetry at home if the patient can obtain it, and clear escalation criteria for ED referral.

Documentation Checklist

For each molnupiravir prescription:

Document clinical rationale for molnupiravir over Paxlovid/remdesivir

Verify and document pregnancy status (required by EUA)

Confirm patient received EUA Fact Sheet

Document contraception counseling

If patient could not fill: document efforts and the alternative plan taken

Cost Assistance: Brief Guide for Your Staff

Lagevrio retails for over $1,000 per 5-day course. Ensure your staff can direct patients to:

Merck Savings Coupon: lagevrio.com/patients/coupon — commercially insured patients may pay as little as $10 per prescription.

Merck Helps Patient Assistance Program: merckhelps.com/LAGEVRIO or 1-800-727-5400 — for uninsured/underinsured patients. Medication may be provided at no cost.

For more detail on the supply situation, see our Molnupiravir Shortage: What Providers Need to Know in 2026.

Bottom Line

Helping patients find molnupiravir isn't just a patient services task — it's a clinical imperative. With a 5-day treatment window, pharmacy access failures translate directly into treatment failures. Build pharmacy-finding workflows into your practice, use available tools like medfinder, and always have a clearly documented backup plan ready.